Genentech layoffs include elimination of infectious disease department

In the latest restructuring, Genentech will lose 29-year veteran Vishva Dixit, the vice president of its physiological chemistry unit; Todd McDevitt, head of cell therapy, and Man-Wah Tan, a vice ...
Fierce Pharma

Genentech, Novartis accused of Xolair kickback scheme in lawsuit

A newly unsealed whistleblower lawsuit accuses Novartis and Genentech of being at the center of a decades-long kickback ...
Business Wire

Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will present more than 30 abstracts across more than 10 ...
STAT

Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...
STAT

Genentech’s cancer pivot, Pfizer’s sickle cell withdrawal, and a new schizophrenia drug

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Aviv Regev

Previously a professor at the Massachusetts Institute of Technology and a leader at the Broad Institute of M.I.T. and Harvard ...

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

“Dr. Sanders has an exceptional track record in developing new technologies,” said Calidi Chairman of the Board Jim Schoeneck. “We believe her deep expertise in the clinical development of novel ...
FiercePharma

Genentech CEO Alexander Hardy warns of 'unintended consequences' from the Inflation Reduction Act

Genentech is working with Congress and the Centers for Medicare and Medicaid Services (CMS) to offer suggestions for changes to IRA. But the company is considering legal action as well, CEO Alexander ...
Business Wire

Ten-Year APHINITY Data Show Genentech’s Perjeta-based Regimen Reduced the Risk of Death by 17% in HER2-Positive Early-Stage Breast Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support ...

Former Genentech exec moves company to Bay Area from Colorado with $400 million in the bank

A company competing with Novartis and Merck to treat people with chronic myeloid leukemia moved from Colorado to the Bay Area ...
Yahoo

Roche’s Genentech present data on trontinemab, Elecsys plasma test

Add Yahoo as a preferred source to see more of our stories on Google. https://www.tipranks.com/news/the-fly/precigen-sees-q1-revenue-exceeding-18m-consensus-20-8m ...
MM&M

Genentech, Orionis Biosciences ink $47M partnership to develop molecular glues

Genentech signed onto a $47 million partnership with biotech Orionis Biosciences to focus on discovering novel small molecule therapies across various therapeutic areas, including cancer and ...